FULC - Fulcrum Therapeutics, Inc.

QQQ $ 612.11 $ 7.61 (1.26 %)

DIA $ 467.12 $ 5.24 (1.13 %)

SPY $ 671.75 $ 6.91 (1.04 %)

TLT $ 91.68 $ 0.35 (0.38 %)

GLD $ 401.36 $ 14.16 (3.64 %)

Previous Close

$ 9.22

Open

$ 9.12

Bid

$ 8.00 x 1,500

Ask

$ 10.00 x 1

Day's Range

$ 8.82 - $ 9.48

52 Week Range

$ 2.32 - $ 9.89

Volume

456,423

Average Volume

Market Cap

498.72M

Beta (5Y Monthly)

$ 1.76

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-29-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	02-25-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	07-31-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	02-27-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-09-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-09-2022	03-31-2022	10-Q
15	03-03-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-10-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-04-2021	12-31-2020	10-K
20	11-10-2020	09-30-2020	10-Q
21	08-11-2020	06-30-2020	10-Q
22	05-13-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-26-2019	06-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Fulc...
10/20/2025 11:56:10

HC Wainwright & Co. analyst Andrew S. Fein reiterates Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and maintains $12 pr...

Fulcrum Therapeutics to Present Preclinica...
10/14/2025 11:11:27

Fulcrum Therapeutics, Inc.® (Fulcrum) (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small mol...

12 Health Care Stocks Moving In Thursday's...
09/25/2025 21:06:11

Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their...

RBC Capital Maintains Sector Perform on Fu...
07/30/2025 14:26:59

RBC Capital analyst Luca Issi maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Sector Perform and raises the price target...

avis-budget-group-posts-downbeat-earnings-joins-sofi-technologies-seagate-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Avis Budget Group Posts Downbeat Earnings,...
07/30/2025 12:05:06

HC Wainwright & Co. Upgrades Fulcrum Thera...
07/29/2025 15:34:05

HC Wainwright & Co. analyst Andrew Fein upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Neutral to Buy and raises the p...

whirlpool-posts-downbeat-earnings-joins-harmonic-stanley-black--decker-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

Whirlpool Posts Downbeat Earnings, Joins H...
07/29/2025 12:20:41

12 Health Care Stocks Moving In Tuesday's ...
07/29/2025 12:07:53

Fulcrum Therapeutics Q2 2025 EPS $(0.28) B...
07/29/2025 10:51:02

Fulcrum Therapeutics Reports Results From ...
07/29/2025 10:47:53

― Robust and clinically meaningful absolute mean fetal hemoglobin (HbF) induction of 8.6% from baseline at 12 weeks of treatmen...

why-celestica-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket

Why Celestica Shares Are Trading Higher By...
07/29/2025 10:46:00

Fulcrum Therapeutics To Present Topline Re...
07/28/2025 20:02:21

Fulcrum Therapeutics, Inc.® (Fulcrum) (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on developing small mol...

Piper Sandler Maintains Overweight on Fulc...
05/29/2025 16:54:46

Piper Sandler analyst Edward Tenthoff maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Overweight and raises the price ta...

Leerink Partners Upgrades Fulcrum Therapeu...
05/23/2025 12:21:17

Leerink Partners analyst Joseph Schwartz upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Market Perform to Outperform and r...

12 Health Care Stocks Moving In Friday's P...
05/23/2025 12:08:30

Cantor Fitzgerald Upgrades Fulcrum Therape...
05/15/2025 15:28:21

Cantor Fitzgerald analyst Kristen Kluska upgrades Fulcrum Therapeutics (NASDAQ:FULC) from Neutral to Overweight and announce...

Fulcrum Therapeutics Expects Current Cash ...
05/01/2025 11:08:15

Cash Runway GuidanceBased on its current operating plans, Fulcrum continues to expect that its current cash, cash equivalents, ...

Fulcrum Therapeutics Q1 EPS $(0.28) Beats ...
05/01/2025 11:06:49

Fulcrum Therapeutics (NASDAQ:FULC) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

Uncovering Potential: Fulcrum Therapeutics...
04/30/2025 20:03:55